Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Venous Thrombosis in Turner Syndrome

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2008 by University of Aarhus.
Recruitment status was:  Active, not recruiting
Information provided by:
University of Aarhus Identifier:
First received: January 7, 2008
Last updated: January 31, 2008
Last verified: January 2008
In the literature, cases of thrombosis in the venous system have been described in girls and women with Turner syndrome. By screening a group of women with Turner syndrome, the researchers wish to find out if this condition is more frequent in this patient population.

Thromboembolic Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: The Risk of Venous Thrombosis in Women With Turner Syndrome

Resource links provided by NLM:

Further study details as provided by University of Aarhus:

Biospecimen Retention:   Samples With DNA

Estimated Enrollment: 60
Study Start Date: June 2006
Estimated Study Completion Date: April 2008
Estimated Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Women with Turner syndrome

Detailed Description:
In the literature cases of thrombosis in the venous system has been described in girls and women with Turner syndrome. By screening a group of women with Turner syndrome we wish to find out if this condition is more frequent in this patient population. Participants are examined with screening blood tests evaluating thromboembolic disturbances.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women with Turner syndrome

Inclusion Criteria:

  • Turner syndrome verified by karyotyping
  • Aged 18 or above

Exclusion Criteria:

  • Malignant disease
  • Treatment with anticoagulants
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00594763

Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital
Aarhus, Aarhus C, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Principal Investigator: Jens Sandahl Christiansen, MD,, professor Medical Department of Endocrinology, Aarhus University Hospital, 8000 Aarhus, Denmark
  More Information

Responsible Party: Jens Sandahl Christiansen, Aarhus University Hospital, Aarhus, Denmark Identifier: NCT00594763     History of Changes
Other Study ID Numbers: 20050045
Study First Received: January 7, 2008
Last Updated: January 31, 2008

Keywords provided by University of Aarhus:
Turner syndrome
Thromboembolic disease

Additional relevant MeSH terms:
Venous Thrombosis
Turner Syndrome
Gonadal Dysgenesis
Primary Ovarian Insufficiency
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Disorders of Sex Development
Urogenital Abnormalities
Sex Chromosome Disorders of Sex Development
Heart Defects, Congenital
Cardiovascular Abnormalities
Heart Diseases
Congenital Abnormalities
Sex Chromosome Disorders
Chromosome Disorders
Genetic Diseases, Inborn
Gonadal Disorders
Endocrine System Diseases
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female processed this record on May 25, 2017